Areas of Expertise (4)
Access to Medical Treatment
Professor Giampiero Favato is Director of the Institute of Leadership and Management in Health at the Kingston Business School in Kingston University. He examines the economics of public health policy - and in particular the economics of inequalities in accessing medical treatments. He has worked on highly successful campaigns to influence changes on immunisation policy - for example: to widen the availability of human papillomavirus vaccines (HPVs) among previously discounted communities.
Giampiero’s early career was in corporate finance, economics and business development roles within the pharmaceutical and life sciences industry. He was the senior director for a joint venture between Schering Plough and Merck Sharp and Dohme, and a Director at Eli Lilly and Co. After 20 years in industry he joined Henley Business School (where was Director the MBA and undertook a DBA). He is a Fellow of the Royal Society of Medicine and a Fellow of the Royal Society of Public Health.
Oxford Brookes University: B.Sc., Governance of Public Health 2009
Brunel University, London: D.B.A., Financial Economics 2003
University of Chicago - Booth School of Business: M.B.A. 1998
- Fellow of the Royal Society of Medicine
- Fellow of the Royal Society of Public Health
Media Mentions (4)
Debate: Should gender analysis be embedded in epidemic responses?
SciDev Net online
Women are on the coronavirus frontlines as healthcare workers and primary caregivers, but policy responses often fail to consider how gender and epidemics interact. Health policies that fail to recognise the different needs of genders cannot effectively mitigate the impacts of pandemics, such as the novel coronavirus.
Public believe more than half of fake news about healthcare spread online, major study reveals
The study, by Professor Giampiero Favato and Dr. Andrea Marcellusi from Kingston Business School, also revealed web banners warning audiences about the potential inaccuracy of information were ineffective in limiting its circulation—with users just as likely to share content labelled as unverified.
Why are boys still being discriminated against over vital cancer jab? HPV campaigner DAVID ROSE fought for the life-saving vaccination only to see his son lose out
Daily Mail online
Professor Giampiero Favato, a health economist at Kingston University London, whose research persuaded Italy to start vaccinating boys years earlier than in Britain, called the Government’s justification for the absence of a catch-up scheme ‘quite possibly the thinnest argument ever used in public health policy’ and said not vaccinating boys over the age of 13 was discriminatory on grounds of gender and age.
HPV: The gender-neutral killer in need of prevention among men
Giampiero Favato is one of them. "Twenty years from now, we will laugh about this discussion," said the health economics specialist at Kingston University. "It is obvious we should vaccinate boys. HPV is a gender-neutral killer. When my son is 12, I will pay for the vaccination if necessary."
Public–private contribution to biopharmaceutical discoveries: a bibliometric analysis of biomedical research in UKScientometrics
2020 Basic research creates new knowledge that fuels technological advances. However, budgetary concerns and escalating R&D prices are challenging organizations to show returns from investments in scientific research. Few attempts are made to analyse research that leads to pharmaceutical innovation.
Channels and processes of knowledge transfer: How does knowledge move between university and industry?Science and Public Policy
2020 The role of knowledge and technology transfer between academia and the industry has received increasing attention in the analysis of innovation. This article aims to explore the scientific literature concerning knowledge transport mechanisms and describe how the topic was organized by previous studies and terminologies applied.
Foresight, cognition, and long‐term performance: Insights from the automotive industry and opportunities for future researchFutures & Foresight Science
2020 We explore the relationship between foresight and managerial cognition and the contribution of foresight to the long‐term performance of organizations facing major sources of uncertainty. Our research setting is the automotive industry, a compelling research setting for illustrating and reflecting upon the role of foresight in strategic decision making, as the industry is currently experiencing major drivers of change and technological discontinuities.
Budget Impact Analysis of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections in Three European CountriesClinical Drug Investigation
2020 Acute bacterial skin and skin structure infections (ABSSSIs) have been defined by the US Food and Drug Administration (FDA) in 2013 to include a subset of complicated skin and skin structure infections commonly treated with parenteral antibiotic therapy. Inpatient treatment of ABSSSIs involves a significant economic burden on the healthcare system.
Intentional rounding in hospital wards to improve regular interaction and engagement between nurses and patients: a realist evaluationHealth Services and Delivery Research
2019 The government response to the care failures at the Mid Staffordshire NHS Foundation Trust led to the policy imperative of ‘regular interaction and engagement between nurses and patients’ (Francis R. Report of the Mid Staffordshire NHS Foundation Trust Public Inquiry.